Before revision:  The challenge is that selective isolation of the symptomatic patients is insufficient to control SARS-CoV-2, due to its relatively long incubation period, in which individuals experience no symptoms, but may already contribute to the spread. How then do we isolate theseinvisible pre-symptomatic spreaders?
After revision:  invisible pre-symptomatic spreaders?